Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis
In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reducti...
Saved in:
Published in | The Lancet infectious diseases Vol. 16; no. 5; pp. 592 - 598 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Ltd
01.05.2016
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 1473-3099 1474-4457 1474-4457 |
DOI | 10.1016/S1473-3099(16)00027-X |
Cover
Abstract | In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage.
We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden.
In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000–201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000–12 000).
Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden.
Dutch Ministry of Health, Welfare and Sport. |
---|---|
AbstractList | Summary Background In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage. Methods We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden. Findings In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000–201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000–12 000). Interpretation Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden. Funding Dutch Ministry of Health, Welfare and Sport. In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage.BACKGROUNDIn the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage.We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden.METHODSWe retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden.In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000-201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000-12 000).FINDINGSIn the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000-201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000-12 000).Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden.INTERPRETATIONOur historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden.Dutch Ministry of Health, Welfare and Sport.FUNDINGDutch Ministry of Health, Welfare and Sport. In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage. We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden. In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000–201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000–12 000). Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden. Dutch Ministry of Health, Welfare and Sport. In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage. Methods We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden. Findings In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000-201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000-12 000). Interpretation Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden. Funding Dutch Ministry of Health, Welfare and Sport. |
Author | van Wijhe, Maarten Postma, Maarten J McDonald, Scott A Wallinga, Jacco de Melker, Hester E |
Author_xml | – sequence: 1 givenname: Maarten surname: van Wijhe fullname: van Wijhe, Maarten email: maarten.van.wijhe@rivm.nl organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands – sequence: 2 givenname: Scott A surname: McDonald fullname: McDonald, Scott A organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands – sequence: 3 givenname: Hester E surname: de Melker fullname: de Melker, Hester E organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands – sequence: 4 givenname: Maarten J surname: Postma fullname: Postma, Maarten J organization: Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, Netherlands – sequence: 5 givenname: Jacco surname: Wallinga fullname: Wallinga, Jacco organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26873665$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1u1TAQhSNURH_gEUCW2JRFwE4cO6EChKryI1WwAKTuLF970uuS2MV2KuVFeF4m97ZCuhIqmyQzOfN5fM5hseeDh6J4yuhLRpl49Y1xWZc17bpjJl5QSitZXjwoDrDNS84bubf53kr2i8OUrihlklH-qNivRCtrIZqD4vdZ34PJJPTkRhvjvM4ueHIdw2XU4wiJYDWGmPXg8kxWU7TgiR6DvyRm7QYbl9JbMocJW9pOQ07EeZLXQL4APuOAvxOxU3QoWNoVzWtiwOcpzq-JJmuXcojO6AFJepiTS4-Lh70eEjy5fR8VPz6cfT_9VJ5__fj59P15aRre5ZKLRrZQN0IYUwveVNJ2LbZWotWVbExtuLasqiUTfU97ScGI3rY1bfH-VvL6qDjecvHCvyZIWY0uGRhwZwhTUqxlsm24bDqUPt-RXoUp4r6oki3naGknUfXsVjWtRrDqOrpRx1ndOY6Ck63AxJBShF4Zlzem56jdoBhVS75qk69awlNYbfJVFzjd7EzfHXDf3LvtHKCZNw6iSsaBN2BdxPiVDe5ewtsdghmcX0L7CTOkv16oVCm6hSwMJjaEBfDm34D_WOAPuQTmDg |
CODEN | LANCAO |
CitedBy_id | crossref_primary_10_3390_vaccines9111290 crossref_primary_10_1016_j_vaccine_2018_12_024 crossref_primary_10_1017_ssh_2023_7 crossref_primary_10_1093_cid_ciw529 crossref_primary_10_1136_bmjopen_2023_072722 crossref_primary_10_3389_fimmu_2020_590780 crossref_primary_10_1016_j_vaccine_2024_126533 crossref_primary_10_1080_17441730_2023_2193077 crossref_primary_10_1186_s41118_021_00143_5 crossref_primary_10_1016_S2214_109X_16_30185_1 crossref_primary_10_1186_s12879_021_06559_w crossref_primary_10_1007_s12445_016_0289_4 crossref_primary_10_1017_S0950268818000481 crossref_primary_10_1016_j_jval_2022_10_011 crossref_primary_10_1016_j_vaccine_2023_10_043 crossref_primary_10_1016_S0001_4079_19_30503_5 crossref_primary_10_1097_EDE_0000000000000778 crossref_primary_10_1007_s00431_021_03997_1 crossref_primary_10_1007_s12452_019_00183_6 crossref_primary_10_1016_j_puhe_2022_09_020 crossref_primary_10_1093_aje_kwy021 crossref_primary_10_1016_S0140_6736_20_32657_X crossref_primary_10_2807_1560_7917_ES_2019_24_18_1800363 crossref_primary_10_1080_07853890_2019_1588470 crossref_primary_10_1142_S2382624X18500121 crossref_primary_10_7774_cevr_2017_6_1_22 crossref_primary_10_1111_jpet_12560 crossref_primary_10_3390_vaccines9020144 crossref_primary_10_2807_1560_7917_ES_2017_22_28_30571 crossref_primary_10_1016_j_vaccine_2020_06_061 crossref_primary_10_1016_j_rico_2023_100236 crossref_primary_10_1371_journal_pmed_1004166 crossref_primary_10_1001_jamanetworkopen_2024_60558 crossref_primary_10_3390_vaccines13030276 crossref_primary_10_1007_s00431_017_2885_0 crossref_primary_10_1016_S1473_3099_16_00060_8 crossref_primary_10_1051_medsci_20173302001 crossref_primary_10_1016_j_vaccine_2019_07_097 crossref_primary_10_1016_j_medmal_2017_01_001 crossref_primary_10_1080_00324728_2023_2243913 crossref_primary_10_1038_s41467_018_07515_0 crossref_primary_10_1098_rsos_230966 crossref_primary_10_1001_jamapediatrics_2018_2349 crossref_primary_10_1002_pds_4419 crossref_primary_10_1093_aje_kwac048 crossref_primary_10_1017_S0950268820002691 crossref_primary_10_1016_j_arcped_2020_06_009 crossref_primary_10_1093_phe_phaa005 crossref_primary_10_1093_phe_phaa008 crossref_primary_10_20304_humanitas_1058039 crossref_primary_10_1007_s10067_020_05059_7 crossref_primary_10_1126_science_aav1003 crossref_primary_10_1098_rspb_2023_0690 crossref_primary_10_1093_ofid_ofy137 crossref_primary_10_1371_journal_pone_0196906 crossref_primary_10_1136_archdischild_2017_313488 |
Cites_doi | 10.1056/NEJMoa0706589 10.1098/rstb.2013.0433 10.1056/NEJMms1215400 10.1016/S0140-6736(94)92091-5 10.2105/AJPH.89.12.1883 10.1093/ije/dyt122 10.1007/BF01796912 10.1111/j.1467-842X.1998.tb01142.x 10.1016/S0277-9536(98)00060-4 10.1098/rspb.2013.2676 10.1136/bmj.h436 10.1001/jama.281.1.61 10.1016/j.vaccine.2009.12.022 10.3201/eid0707.017743 10.1098/rspb.2013.2438 10.1111/j.1467-842X.1998.tb01141.x 10.1002/sim.5903 10.4054/DemRes.2013.29.41 10.1093/ije/26.4.772 10.1038/35015561 10.1016/S0264-410X(02)00587-X 10.1001/jama.298.18.2155 10.1016/S0140-6736(86)92270-1 10.1016/S0140-6736(06)68848-X 10.1016/S0140-6736(04)17593-4 |
ContentType | Journal Article |
Copyright | 2016 Elsevier Ltd Elsevier Ltd Copyright © 2016 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited May 2016 |
Copyright_xml | – notice: 2016 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2016 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited May 2016 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 0TZ 3V. 7QL 7RV 7U9 7X7 7XB 88E 8AO 8C1 8C2 8FI 8FJ 8FK ABUWG AEUYN AFKRA BENPR C1K CCPQU FYUFA GHDGH H94 K9. KB0 M0S M1P M7N NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 |
DOI | 10.1016/S1473-3099(16)00027-X |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Pharma and Biotech Premium PRO ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Lancet Titles Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database (ProQuest) Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Pharma and Biotech Premium PRO ProQuest One Academic Middle East (New) Lancet Titles ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Pharma and Biotech Premium PRO MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1474-4457 |
EndPage | 598 |
ExternalDocumentID | 4036093051 26873665 10_1016_S1473_3099_16_00027_X S147330991600027X 1_s2_0_S147330991600027X |
Genre | Historical Article Journal Article |
GeographicLocations | Netherlands |
GeographicLocations_xml | – name: Netherlands |
GrantInformation | Dutch Ministry of Health, Welfare and Sport. |
GroupedDBID | --- --K --M -RU ..I .1- .FO 0R~ 123 1B1 1P~ 1~5 29L 4.4 457 4G. 53G 5VS 6PF 7-5 71M 7RV 7X7 88E 8AO 8C1 8C2 8FI 8FJ AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AAQXK AARKO AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABJNI ABMAC ABMZM ABUWG ABWVN ACGFS ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AHMBA AIGII AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BENPR BKEYQ BKOJK BNPGV BPHCQ BVXVI CCPQU CJTIS CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-Q GBLVA HF~ HMCUK HVGLF HZ~ IHE J1W KOM M1P M41 MO0 N9A NAPCQ O-L O9- OD- OO. OZT P-8 P-9 P2P PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO R2- ROL RPZ SDG SEL SES SPCBC SSH SSI SSZ T5K TLN UKHRP UV1 WOW XBR Z5R 3V. AACTN AAYOK AFCTW AFKWA AJOXV ALIPV AMFUW RIG SDF ABLVK ABYKQ AJBFU ZA5 AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 0TZ 7QL 7U9 7XB 8FK C1K H94 K9. M7N PKEHL PQEST PQUKI 7X8 ACLOT ~HD |
ID | FETCH-LOGICAL-c549t-46578e3566cc364527d98578b68a275c3c4ad123716ff0f70ec6fd8308873d743 |
IEDL.DBID | 7X7 |
ISSN | 1473-3099 1474-4457 |
IngestDate | Sat Sep 27 20:12:39 EDT 2025 Sat Jul 26 01:03:15 EDT 2025 Thu Apr 03 07:00:05 EDT 2025 Tue Jul 01 01:42:49 EDT 2025 Thu Apr 24 23:04:18 EDT 2025 Fri Feb 23 02:26:57 EST 2024 Tue Feb 25 19:56:55 EST 2025 Tue Aug 26 17:35:16 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | Copyright © 2016 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c549t-46578e3566cc364527d98578b68a275c3c4ad123716ff0f70ec6fd8308873d743 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://www.thelancet.com/article/S147330991600027X/pdf |
PMID | 26873665 |
PQID | 1784468797 |
PQPubID | 44001 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1817854759 proquest_journals_1784468797 pubmed_primary_26873665 crossref_citationtrail_10_1016_S1473_3099_16_00027_X crossref_primary_10_1016_S1473_3099_16_00027_X elsevier_sciencedirect_doi_10_1016_S1473_3099_16_00027_X elsevier_clinicalkeyesjournals_1_s2_0_S147330991600027X elsevier_clinicalkey_doi_10_1016_S1473_3099_16_00027_X |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-05-01 |
PublicationDateYYYYMMDD | 2016-05-01 |
PublicationDate_xml | – month: 05 year: 2016 text: 2016-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: London |
PublicationTitle | The Lancet infectious diseases |
PublicationTitleAlternate | Lancet Infect Dis |
PublicationYear | 2016 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | Dayan, Quinlisk, Parker (bib25) 2008; 358 Taylor, Lewis, Powles (bib16) 1998; 22 Oostvogel, van Wijngaarden, van der Avoort (bib27) 1994; 344 Breiman, Streatfield, Phelan, Shifa, Rashid, Yunus (bib3) 2004; 364 (bib7) 2011; 60 Andersen, Canudas-Romo, Keiding (bib13) 2013; 29 Wolleswinkel-van den Bosch, van Poppel, Tabeau, Mackenbach (bib18) 1998; 47 van Panhuis, Grefenstette, Jung (bib5) 2013; 369 Hinman, Orenstein, Schuchat (bib8) 2011; 60 Kata (bib9) 2010; 28 Mackenbach, Looman (bib17) 2013; 42 Crowcroft, Pebody (bib24) 2006; 367 Peltola, Karanko, Kurki (bib23) 1986; 1 Armstrong, Conn, Pinner (bib2) 1999; 281 DiLiberti, Jackson (bib10) 1999; 89 de Melker, van den Hof, Berbers, Conyn-van Spaendonck (bib21) 2003; 21 Taylor, Lewis, Powles (bib15) 1998; 22 Wolleswinkel-van den Bosch, Looman, Van Poppel, Mackenbach (bib14) 1997; 26 Merler, Ajelli (bib19) 2014; 281 Greenwood (bib6) 2014; 369 Janssen, Kunst (bib22) 2004; 82 Martinez-Bakker, Bakker, King, Rohani (bib20) 2014; 281 Andersen (bib12) 2013; 32 van den Hof, Meffre, Conyn-van Spaendonck, Woonink, de Melker, van Binnendijk (bib26) 2001; 7 McCarthy (bib28) 2015; 350 Wolleswinkel-van den Bosch, Van Poppel, Mackenbach (bib11) 1996; 12 Roush, Murphy (bib4) 2007; 298 Tuljapurkar, Li, Boe (bib1) 2000; 405 Wolleswinkel-van den Bosch (10.1016/S1473-3099(16)00027-X_bib11) 1996; 12 Dayan (10.1016/S1473-3099(16)00027-X_bib25) 2008; 358 Mackenbach (10.1016/S1473-3099(16)00027-X_bib17) 2013; 42 Andersen (10.1016/S1473-3099(16)00027-X_bib12) 2013; 32 Peltola (10.1016/S1473-3099(16)00027-X_bib23) 1986; 1 Taylor (10.1016/S1473-3099(16)00027-X_bib16) 1998; 22 (10.1016/S1473-3099(16)00027-X_bib7) 2011; 60 Hinman (10.1016/S1473-3099(16)00027-X_bib8) 2011; 60 Oostvogel (10.1016/S1473-3099(16)00027-X_bib27) 1994; 344 Crowcroft (10.1016/S1473-3099(16)00027-X_bib24) 2006; 367 Roush (10.1016/S1473-3099(16)00027-X_bib4) 2007; 298 Andersen (10.1016/S1473-3099(16)00027-X_bib13) 2013; 29 Wolleswinkel-van den Bosch (10.1016/S1473-3099(16)00027-X_bib14) 1997; 26 DiLiberti (10.1016/S1473-3099(16)00027-X_bib10) 1999; 89 Breiman (10.1016/S1473-3099(16)00027-X_bib3) 2004; 364 McCarthy (10.1016/S1473-3099(16)00027-X_bib28) 2015; 350 Armstrong (10.1016/S1473-3099(16)00027-X_bib2) 1999; 281 Janssen (10.1016/S1473-3099(16)00027-X_bib22) 2004; 82 Kata (10.1016/S1473-3099(16)00027-X_bib9) 2010; 28 Taylor (10.1016/S1473-3099(16)00027-X_bib15) 1998; 22 van Panhuis (10.1016/S1473-3099(16)00027-X_bib5) 2013; 369 Wolleswinkel-van den Bosch (10.1016/S1473-3099(16)00027-X_bib18) 1998; 47 Greenwood (10.1016/S1473-3099(16)00027-X_bib6) 2014; 369 van den Hof (10.1016/S1473-3099(16)00027-X_bib26) 2001; 7 Merler (10.1016/S1473-3099(16)00027-X_bib19) 2014; 281 Tuljapurkar (10.1016/S1473-3099(16)00027-X_bib1) 2000; 405 Martinez-Bakker (10.1016/S1473-3099(16)00027-X_bib20) 2014; 281 de Melker (10.1016/S1473-3099(16)00027-X_bib21) 2003; 21 26873664 - Lancet Infect Dis. 2016 May;16(5):516-518 |
References_xml | – volume: 29 start-page: 1127 year: 2013 end-page: 1152 ident: bib13 article-title: Cause-specific measure of life years lost publication-title: Demogr Res – volume: 1 start-page: 137 year: 1986 end-page: 139 ident: bib23 article-title: Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland publication-title: Lancet – volume: 369 start-page: 2152 year: 2013 end-page: 2158 ident: bib5 article-title: Contagious diseases in the United States from 1888 to the present publication-title: N Engl J Med – volume: 89 start-page: 1883 year: 1999 end-page: 1885 ident: bib10 article-title: Long-term trends in childhood infectious disease mortality rates publication-title: Am J Public Health – volume: 7 start-page: 593 year: 2001 end-page: 597 ident: bib26 article-title: Measles outbreak in a community with very low vaccine coverage, the Netherlands publication-title: Emerg Infect Dis – volume: 60 start-page: 49 year: 2011 end-page: 57 ident: bib8 article-title: Vaccine-preventable diseases, immunizations, and MMWR–1961–2011 publication-title: MMWR Surveill Summ – volume: 405 start-page: 789 year: 2000 end-page: 792 ident: bib1 article-title: A universal pattern of mortality decline in the G7 countries publication-title: Nature – volume: 369 start-page: 20130433 year: 2014 ident: bib6 article-title: The contribution of vaccination to global health: past, present and future publication-title: Philos Trans R Soc Lond B Biol Sci – volume: 42 start-page: 1100 year: 2013 end-page: 1110 ident: bib17 article-title: Life expectancy and national income in Europe, 1900-2008: an update of Preston's analysis publication-title: Int J Epidemiol – volume: 22 start-page: 27 year: 1998 end-page: 36 ident: bib16 article-title: The Australian mortality decline: all-cause mortality 1788–1990 publication-title: Aust N Z J Public Health – volume: 281 start-page: 61 year: 1999 end-page: 66 ident: bib2 article-title: Trends in infectious disease mortality in the United States during the 20th century publication-title: JAMA – volume: 298 start-page: 2155 year: 2007 end-page: 2163 ident: bib4 article-title: Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States publication-title: JAMA – volume: 22 start-page: 37 year: 1998 end-page: 44 ident: bib15 article-title: The Australian mortality decline: cause-specific mortality 1907–1990 publication-title: Aust N Z J Public Health – volume: 350 start-page: h436 year: 2015 ident: bib28 article-title: Measles outbreak linked to Disney theme parks reaches five states and Mexico publication-title: BMJ – volume: 12 start-page: 327 year: 1996 end-page: 361 ident: bib11 article-title: Reclassifying the causes of death to study the epidemiological transition in the Netherlands, 1875–1992 publication-title: Eur J Popul – volume: 60 start-page: 814 year: 2011 end-page: 818 ident: bib7 article-title: Ten great public health achievements—worldwide, 2001–2010 publication-title: MMWR Morb Mortal Wkly Rep – volume: 47 start-page: 429 year: 1998 end-page: 443 ident: bib18 article-title: Mortality decline in the Netherlands in the period 1850–1992: a turning point analysis publication-title: Soc Sci Med – volume: 82 start-page: 904 year: 2004 end-page: 913 ident: bib22 article-title: ICD coding changes and discontinuities in trends in cause-specific mortality in six European countries, 1950–99 publication-title: Bull World Health Organ – volume: 344 start-page: 665 year: 1994 end-page: 670 ident: bib27 article-title: Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992–93 publication-title: Lancet – volume: 26 start-page: 772 year: 1997 end-page: 781 ident: bib14 article-title: Cause-specific mortality trends in the Netherlands, 1875–1992: a formal analysis of the epidemiologic transition publication-title: Int J Epidemiol – volume: 281 start-page: 20132676 year: 2014 ident: bib19 article-title: Deciphering the relative weights of demographic transition and vaccination in the decrease of measles incidence in Italy publication-title: Proc Biol Sci – volume: 281 start-page: 20132438 year: 2014 ident: bib20 article-title: Human birth seasonality: latitudinal gradient and interplay with childhood disease dynamics publication-title: Proc Biol Sci – volume: 21 start-page: 716 year: 2003 end-page: 720 ident: bib21 article-title: Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and publication-title: Vaccine – volume: 358 start-page: 1580 year: 2008 end-page: 1589 ident: bib25 article-title: Recent resurgence of mumps in the United States publication-title: N Engl J Med – volume: 364 start-page: 2204 year: 2004 end-page: 2211 ident: bib3 article-title: Effect of infant immunisation on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data publication-title: Lancet – volume: 28 start-page: 1709 year: 2010 end-page: 1716 ident: bib9 article-title: A postmodern Pandora's box: anti-vaccination misinformation on the Internet publication-title: Vaccine – volume: 32 start-page: 5278 year: 2013 end-page: 5285 ident: bib12 article-title: Decomposition of number of life years lost according to causes of death publication-title: Stat Med – volume: 367 start-page: 1926 year: 2006 end-page: 1936 ident: bib24 article-title: Recent developments in pertussis publication-title: Lancet – volume: 358 start-page: 1580 year: 2008 ident: 10.1016/S1473-3099(16)00027-X_bib25 article-title: Recent resurgence of mumps in the United States publication-title: N Engl J Med doi: 10.1056/NEJMoa0706589 – volume: 369 start-page: 20130433 year: 2014 ident: 10.1016/S1473-3099(16)00027-X_bib6 article-title: The contribution of vaccination to global health: past, present and future publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2013.0433 – volume: 369 start-page: 2152 year: 2013 ident: 10.1016/S1473-3099(16)00027-X_bib5 article-title: Contagious diseases in the United States from 1888 to the present publication-title: N Engl J Med doi: 10.1056/NEJMms1215400 – volume: 344 start-page: 665 year: 1994 ident: 10.1016/S1473-3099(16)00027-X_bib27 article-title: Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992–93 publication-title: Lancet doi: 10.1016/S0140-6736(94)92091-5 – volume: 89 start-page: 1883 year: 1999 ident: 10.1016/S1473-3099(16)00027-X_bib10 article-title: Long-term trends in childhood infectious disease mortality rates publication-title: Am J Public Health doi: 10.2105/AJPH.89.12.1883 – volume: 42 start-page: 1100 year: 2013 ident: 10.1016/S1473-3099(16)00027-X_bib17 article-title: Life expectancy and national income in Europe, 1900-2008: an update of Preston's analysis publication-title: Int J Epidemiol doi: 10.1093/ije/dyt122 – volume: 60 start-page: 49 issue: suppl 4 year: 2011 ident: 10.1016/S1473-3099(16)00027-X_bib8 article-title: Vaccine-preventable diseases, immunizations, and MMWR–1961–2011 publication-title: MMWR Surveill Summ – volume: 12 start-page: 327 year: 1996 ident: 10.1016/S1473-3099(16)00027-X_bib11 article-title: Reclassifying the causes of death to study the epidemiological transition in the Netherlands, 1875–1992 publication-title: Eur J Popul doi: 10.1007/BF01796912 – volume: 22 start-page: 37 year: 1998 ident: 10.1016/S1473-3099(16)00027-X_bib15 article-title: The Australian mortality decline: cause-specific mortality 1907–1990 publication-title: Aust N Z J Public Health doi: 10.1111/j.1467-842X.1998.tb01142.x – volume: 82 start-page: 904 year: 2004 ident: 10.1016/S1473-3099(16)00027-X_bib22 article-title: ICD coding changes and discontinuities in trends in cause-specific mortality in six European countries, 1950–99 publication-title: Bull World Health Organ – volume: 47 start-page: 429 year: 1998 ident: 10.1016/S1473-3099(16)00027-X_bib18 article-title: Mortality decline in the Netherlands in the period 1850–1992: a turning point analysis publication-title: Soc Sci Med doi: 10.1016/S0277-9536(98)00060-4 – volume: 281 start-page: 20132676 year: 2014 ident: 10.1016/S1473-3099(16)00027-X_bib19 article-title: Deciphering the relative weights of demographic transition and vaccination in the decrease of measles incidence in Italy publication-title: Proc Biol Sci doi: 10.1098/rspb.2013.2676 – volume: 350 start-page: h436 year: 2015 ident: 10.1016/S1473-3099(16)00027-X_bib28 article-title: Measles outbreak linked to Disney theme parks reaches five states and Mexico publication-title: BMJ doi: 10.1136/bmj.h436 – volume: 281 start-page: 61 year: 1999 ident: 10.1016/S1473-3099(16)00027-X_bib2 article-title: Trends in infectious disease mortality in the United States during the 20th century publication-title: JAMA doi: 10.1001/jama.281.1.61 – volume: 28 start-page: 1709 year: 2010 ident: 10.1016/S1473-3099(16)00027-X_bib9 article-title: A postmodern Pandora's box: anti-vaccination misinformation on the Internet publication-title: Vaccine doi: 10.1016/j.vaccine.2009.12.022 – volume: 7 start-page: 593 issue: suppl 3 year: 2001 ident: 10.1016/S1473-3099(16)00027-X_bib26 article-title: Measles outbreak in a community with very low vaccine coverage, the Netherlands publication-title: Emerg Infect Dis doi: 10.3201/eid0707.017743 – volume: 281 start-page: 20132438 year: 2014 ident: 10.1016/S1473-3099(16)00027-X_bib20 article-title: Human birth seasonality: latitudinal gradient and interplay with childhood disease dynamics publication-title: Proc Biol Sci doi: 10.1098/rspb.2013.2438 – volume: 22 start-page: 27 year: 1998 ident: 10.1016/S1473-3099(16)00027-X_bib16 article-title: The Australian mortality decline: all-cause mortality 1788–1990 publication-title: Aust N Z J Public Health doi: 10.1111/j.1467-842X.1998.tb01141.x – volume: 32 start-page: 5278 year: 2013 ident: 10.1016/S1473-3099(16)00027-X_bib12 article-title: Decomposition of number of life years lost according to causes of death publication-title: Stat Med doi: 10.1002/sim.5903 – volume: 29 start-page: 1127 year: 2013 ident: 10.1016/S1473-3099(16)00027-X_bib13 article-title: Cause-specific measure of life years lost publication-title: Demogr Res doi: 10.4054/DemRes.2013.29.41 – volume: 26 start-page: 772 year: 1997 ident: 10.1016/S1473-3099(16)00027-X_bib14 article-title: Cause-specific mortality trends in the Netherlands, 1875–1992: a formal analysis of the epidemiologic transition publication-title: Int J Epidemiol doi: 10.1093/ije/26.4.772 – volume: 405 start-page: 789 year: 2000 ident: 10.1016/S1473-3099(16)00027-X_bib1 article-title: A universal pattern of mortality decline in the G7 countries publication-title: Nature doi: 10.1038/35015561 – volume: 21 start-page: 716 year: 2003 ident: 10.1016/S1473-3099(16)00027-X_bib21 article-title: Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b publication-title: Vaccine doi: 10.1016/S0264-410X(02)00587-X – volume: 298 start-page: 2155 year: 2007 ident: 10.1016/S1473-3099(16)00027-X_bib4 article-title: Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States publication-title: JAMA doi: 10.1001/jama.298.18.2155 – volume: 60 start-page: 814 year: 2011 ident: 10.1016/S1473-3099(16)00027-X_bib7 article-title: Ten great public health achievements—worldwide, 2001–2010 publication-title: MMWR Morb Mortal Wkly Rep – volume: 1 start-page: 137 year: 1986 ident: 10.1016/S1473-3099(16)00027-X_bib23 article-title: Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland publication-title: Lancet doi: 10.1016/S0140-6736(86)92270-1 – volume: 367 start-page: 1926 year: 2006 ident: 10.1016/S1473-3099(16)00027-X_bib24 article-title: Recent developments in pertussis publication-title: Lancet doi: 10.1016/S0140-6736(06)68848-X – volume: 364 start-page: 2204 year: 2004 ident: 10.1016/S1473-3099(16)00027-X_bib3 article-title: Effect of infant immunisation on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data publication-title: Lancet doi: 10.1016/S0140-6736(04)17593-4 – reference: 26873664 - Lancet Infect Dis. 2016 May;16(5):516-518 |
SSID | ssj0017104 |
Score | 2.455032 |
Snippet | In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However,... Summary Background In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor.... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 592 |
SubjectTerms | Adolescent Child Child, Preschool Communicable Diseases - history Communicable Diseases - mortality Diphtheria - mortality History, 20th Century History, 21st Century Humans Immunization Immunization Programs - history Infant Infectious Disease Infectious diseases Mass Vaccination - history Mass Vaccination - methods Mass Vaccination - statistics & numerical data Measles-Mumps-Rubella Vaccine Mortality Mumps Netherlands Public health Smallpox Vaccines Whooping Cough - mortality Young Adult Young adults |
Title | Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S147330991600027X https://www.clinicalkey.es/playcontent/1-s2.0-S147330991600027X https://dx.doi.org/10.1016/S1473-3099(16)00027-X https://www.ncbi.nlm.nih.gov/pubmed/26873665 https://www.proquest.com/docview/1784468797 https://www.proquest.com/docview/1817854759 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1baxUxEA7agghFtN5OW8sIPuhD7G6ym83xRbS0FKFF1MK-hWySpYLd07qnQv-Iv7eTy6Y-WOvLwubk24Uzm5lvMpkZQl5JIXzwp6ddpSWtrO4oWkFBmXWWddJwXfls5MMjcXBcfWrrNm24jelY5aQTg6K2C-P3yHfKRqLnIpt58_7snPquUT66mlpo3CWrJTIR37qhabPDVaL1DFHlquGUIxW6zuDZ-ZoHX5fiTQjA0fYm23QT9ww2aP8heZDII3yI0n5E7rhhndw7TOHxdbIWN-Eg5hY9Jr9jbWJY9PBLG5wTxADpTNapGwHvTgMBRzIOXUhpgNB_CKYsb9CDhUuvEyDU6hjh-wDIGuGPVGGIyY5hmBXLEzDRlL0DDSe5Dgk-KRZAeUKO9_e-7R7Q1IiBGnQfl7QSuK4dR-ZnjA9bssbOJQ51QmrW1IabSls0geh79X3RN4UzoreSew3GLXKUp2RlWAzuOQFbd471HaoC5AWcFXPGOvR4WF_VJTe1nJFqEoEyqUq5b5bxQ-XjaF5yyktOlf5IHkpOtTPyNsPOYpmO2wBikq-aclBRayo0JLcBm78B3ZjW_qhKNTJVRLQHlyJAESkzMtGbSFv-56Vb0yeort-TV8SMvMw_o3bwIR89uMUFzpE4q_Y1HWfkWfx08__DEMuFqDf-_fBNch9JooiHPLfIyvLnhXuBRGzZbYfVhle5W26T1Y97R5-_XAGjNi0k |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VrQRICEH5WygwSCDBIe3GcRxvpQrx02pLuysErbQ3k9iOWolmC9mC-iI8Ds_WsZ2kHCjl0uN68zlSxp75xuOZAXguhXDBnzIqeC4jbvIiIisoImasYYXUSc5dNvJ4IkZ7_MM0nS7A7zYXxl2rbHWiV9Rmpt0Z-WqcSfJcZDbMXh99i1zXKBddbVto5E1rBbPuS4w1iR3b9uQnuXD1-tZ7kvcLxjY3dt-NoqbLQKTJN5pHXNCitQnRGq1dTI5lZihpqBAyZ1mqE81zQ_qdHIuyHJTZwGpRGpm47ZkYMsA07xVY5O4ApQeLbzcmHz91cQyy3z6uzbMkSoiMneUQrX7uBl_G4pUPAUbT86zjeezXW8HNW3Czoa_4Jqy327BgqyW4Om4C9EtwIxwDYshuugO_QnVknJX4g77eQTh7xOZW2KGtkX4deheA3AEsfFIF-g5I2OaZY14ZPHFaCX21kBoPKiTein8kK2NIt_TDbDDfRx2M6RrmuN9VQqGZQgmWu7B3KUK6B71qVtkHgCYtLCsLUkbETBI2GDJWkM_FSp7GiU5lH3grAqWbOumuXcdX1V2Ic5JTTnIqdpcCSXJq2oeVDnYUCoVcBBCtfFWbBUt6W5EpuwiY_Q1o60b71CpWNVODgHbgWHgoIWWHbAhWIE7_89Lldgmqs_d0e7IPz7q_ST-5oFNe2dkxPSPpqdRVlezD_bB0u-_DCJsIkT789-RP4dpod7yjdrYm24_gOlFWEa6cLkNv_v3YPiZaOC-eNHsP4ctlb_dTX7ZsFw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFB5qC0UQ0XpbrXoEBX2YbjKTTGaFImq7tNYuRS3s25jMTGjBZqvZKv0j_ih_lWcuSX2w1pc-7my-CeTMuc25EfJUCuGCPzWtslLSzJQVRS0oKDPWsEpqXmauGnl3Irb2s3fTfLpAfnW1MC6tspOJXlCbmXZ35MO0kOi5yGJUDOuYFrG3MX51_JW6CVIu0tqN0yjjmAWz7tuNxSKPHXv6A925dn17A2n_jLHx5qe3WzROHKAa_aQ5zQQeYMvRxNHaxedYYUYSlyohS1bkmuusNCjr0cmo66QuEqtFbSR3rMoNKmPc9wpZKlDroyO49GZzsvehj2mgLvcx7qzglKNhdlZPNPzYLz5PxQsfDqTT8zTleZaw14jjG-R6NGXhdTh7N8mCbVbI8m4M1q-Qa-FKEEKl0y3yM3RKhlkN3_HrHYZ7SIgZYke2Bfx15N0BdA2g8gUW4KchQVdzDmVj4NRJKPCdQ1o4bABtWPijcBlC6aVfZsn8AHRQrC-hhIO-KwruFNqx3Cb7l0KkO2SxmTX2HgGTV5bVFQomtFI4S0aMVeh_sTrLU65zOSBZRwKlY890N7rji-qT4xzllKOcSl2CIFJOTQdkrYcdh6YhFwFER1_VVcSiDFeo1i4CFn8D2jZKolalqmUqCWgHToWHIlL2yGhsBSPqf1662h1Bdfaenj8H5En_N8oqF4AqGzs7wWckPpW7DpMDcjcc3f77MMRyIfL7_978MVlGtlfvtyc7D8hVtF5FyD5dJYvzbyf2IVqI8-pRZD0gny-b238DILhwWw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+vaccination+programmes+on+mortality+burden+among+children+and+young+adults+in+the+Netherlands+during+the+20th+century%3A+a+historical+analysis&rft.jtitle=The+Lancet+infectious+diseases&rft.au=van+Wijhe%2C+Maarten&rft.au=McDonald%2C+Scott+A&rft.au=de+Melker%2C+Hester+E&rft.au=Postma%2C+Maarten+J&rft.date=2016-05-01&rft.pub=Elsevier+Ltd&rft.issn=1473-3099&rft.eissn=1474-4457&rft.volume=16&rft.issue=5&rft.spage=592&rft.epage=598&rft_id=info:doi/10.1016%2FS1473-3099%2816%2900027-X&rft.externalDocID=S147330991600027X |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-3099&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-3099&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-3099&client=summon |